16144233 CANADA INC. – Trademark Portfolio
Entity Type: 03
16144233 CANADA INC. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 1 filings in this category. The portfolio also extends into Class 9 (Computers & Electronics) across 5 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include NEURORX. The owner is based in MONTR�AL.
5322-3575, AV. DU PARC
MONTR�AL H2X 3P9 , CA
Showing of trademarks Trademarks
Trademark Classifications
16144233 CANADA INC.'s trademark portfolio spans 5 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does 16144233 CANADA INC. have?
16144233 CANADA INC. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.
What trademark classes does 16144233 CANADA INC. file in?
16144233 CANADA INC. files trademarks across 5 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 44 (Medical Services), Class 38 (Telecommunications). Class 42 covers scientific and technological services; industrial analysis and research services.
What are 16144233 CANADA INC.'s most well-known trademarks?
16144233 CANADA INC.'s registered trademark portfolio includes well-known marks such as NEURORX. These are among 1 currently registered trademark in the portfolio.
What is 16144233 CANADA INC.'s trademark registration success rate?
16144233 CANADA INC. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.